1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Premature Labor Treatment Revenue
1.4 Market by Type
1.4.1 Global Premature Labor Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Progesterone
1.4.3 OBE-022
1.4.4 Retosiban
1.4.5 Others
1.5 Market by Application
1.5.1 Global Premature Labor Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Premature Labor Treatment Market Perspective (2015-2026)
2.2 Global Premature Labor Treatment Growth Trends by Regions
2.2.1 Premature Labor Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Premature Labor Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Premature Labor Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Premature Labor Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Premature Labor Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Premature Labor Treatment Players by Market Size
3.1.1 Global Top Premature Labor Treatment Players by Revenue (2015-2020)
3.1.2 Global Premature Labor Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Premature Labor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Premature Labor Treatment Market Concentration Ratio
3.2.1 Global Premature Labor Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Premature Labor Treatment Revenue in 2019
3.3 Premature Labor Treatment Key Players Head office and Area Served
3.4 Key Players Premature Labor Treatment Product Solution and Service
3.5 Date of Enter into Premature Labor Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Premature Labor Treatment Historic Market Size by Type (2015-2020)
4.2 Global Premature Labor Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Premature Labor Treatment Market Size by Application (2015-2020)
5.2 Global Premature Labor Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Premature Labor Treatment Market Size (2015-2020)
6.2 Premature Labor Treatment Key Players in North America (2019-2020)
6.3 North America Premature Labor Treatment Market Size by Type (2015-2020)
6.4 North America Premature Labor Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Premature Labor Treatment Market Size (2015-2020)
7.2 Premature Labor Treatment Key Players in Europe (2019-2020)
7.3 Europe Premature Labor Treatment Market Size by Type (2015-2020)
7.4 Europe Premature Labor Treatment Market Size by Application (2015-2020)
8 China
8.1 China Premature Labor Treatment Market Size (2015-2020)
8.2 Premature Labor Treatment Key Players in China (2019-2020)
8.3 China Premature Labor Treatment Market Size by Type (2015-2020)
8.4 China Premature Labor Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Premature Labor Treatment Market Size (2015-2020)
9.2 Premature Labor Treatment Key Players in Japan (2019-2020)
9.3 Japan Premature Labor Treatment Market Size by Type (2015-2020)
9.4 Japan Premature Labor Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Premature Labor Treatment Market Size (2015-2020)
10.2 Premature Labor Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Premature Labor Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Premature Labor Treatment Market Size by Application (2015-2020)
11 India
11.1 India Premature Labor Treatment Market Size (2015-2020)
11.2 Premature Labor Treatment Key Players in India (2019-2020)
11.3 India Premature Labor Treatment Market Size by Type (2015-2020)
11.4 India Premature Labor Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Premature Labor Treatment Market Size (2015-2020)
12.2 Premature Labor Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Premature Labor Treatment Market Size by Type (2015-2020)
12.4 Central & South America Premature Labor Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AMAG Pharmaceuticals Inc
13.1.1 AMAG Pharmaceuticals Inc Company Details
13.1.2 AMAG Pharmaceuticals Inc Business Overview
13.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Introduction
13.1.4 AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020))
13.1.5 AMAG Pharmaceuticals Inc Recent Development
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Details
13.2.2 GlaxoSmithKline Plc Business Overview
13.2.3 GlaxoSmithKline Plc Premature Labor Treatment Introduction
13.2.4 GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline Plc Recent Development
13.3 Juniper Pharmaceuticals Inc
13.3.1 Juniper Pharmaceuticals Inc Company Details
13.3.2 Juniper Pharmaceuticals Inc Business Overview
13.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Introduction
13.3.4 Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020)
13.3.5 Juniper Pharmaceuticals Inc Recent Development
13.4 Kissei Pharmaceutical Co Ltd
13.4.1 Kissei Pharmaceutical Co Ltd Company Details
13.4.2 Kissei Pharmaceutical Co Ltd Business Overview
13.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Introduction
13.4.4 Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2015-2020)
13.4.5 Kissei Pharmaceutical Co Ltd Recent Development
13.5 Lipocine Inc
13.5.1 Lipocine Inc Company Details
13.5.2 Lipocine Inc Business Overview
13.5.3 Lipocine Inc Premature Labor Treatment Introduction
13.5.4 Lipocine Inc Revenue in Premature Labor Treatment Business (2015-2020)
13.5.5 Lipocine Inc Recent Development
13.6 ObsEva SA
13.6.1 ObsEva SA Company Details
13.6.2 ObsEva SA Business Overview
13.6.3 ObsEva SA Premature Labor Treatment Introduction
13.6.4 ObsEva SA Revenue in Premature Labor Treatment Business (2015-2020)
13.6.5 ObsEva SA Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
AMAG Pharmaceuticals Inc、GlaxoSmithKline Plc、Juniper Pharmaceuticals Inc、Kissei Pharmaceutical Co Ltd、Lipocine Inc、ObsEva SA
【免責事項】
https://www.globalresearch.jp/disclaimer